Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion.
Peter S. Hendricks, Charles D. Nichols, Kathryn A. Cunningham, Mark A. Geyer, Roland Griffiths, David Nichols
Psychedelic Med (New Rochelle) March 13, 2023 DOI: 10.1089/psymed.2022.0003 via PubMed Central
Summary
AI-generated from the abstractA roundtable discussion among experts traces the history, current state, and future directions of psychedelic medicine. Participants review the early research era of the mid-20th century, the subsequent decades of prohibition, and the recent resurgence of clinical trials exploring psychedelics for mental health conditions. The conversation highlights therapeutic applications of substances such as psilocybin and MDMA, emphasizing their potential to treat depression, PTSD, and addiction. Experts also address challenges including regulatory hurdles, the need for trained therapists, and the importance of integrating these treatments into mainstream healthcare. The discussion concludes with cautious optimism about the field's trajectory.
Study at a glance
| Characteristics | Roundtable discussion Peer reviewed |
|---|---|
| Keywords | Psychedelics: powerful compounds Transformative healing Medical applications: medicine Healthcare Clinical applications |
| Citations | 7 |
| Key finding | Psychedelic medicine is undergoing a renaissance with growing evidence for therapeutic applications, but significant regulatory and integration challenges remain. |
Abstract
Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion.